8-K: Netcapital Issues $290K Convertible Note and Warrants
Financing Agreement
Netcapital Inc. entered into a securities purchase agreement with Labrys Fund II, L.P. to issue a $290,000 convertible promissory note and warrants to purchase 250,000 shares of common stock.
Summary
- Netcapital Inc. issued a $290,000 convertible promissory note to Labrys Fund II, L.P. on May 12, 2026.
- The note includes a $40,000 original issue discount (OID) and a 12% one-time interest charge ($34,800), totaling $290,000 in principal.
- The company also issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.50 per share.
- Net proceeds to the company were $224,500 after deducting $6,500 for buyer legal fees, $1,500 for due diligence, and $17,500 for placement agent fees.
- The note matures on May 12, 2027, with mandatory amortization payments beginning November 12, 2026.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a negative development due to the high cost of capital, the dilutive nature of the conversion terms, and the restrictive covenants that limit operational flexibility.
Positives
- Secured $224,500 in net working capital to support business development.
- The note provides a clear path for conversion into equity, potentially reducing cash repayment obligations if the stock price performs well.
Negatives
- The transaction includes a significant original issue discount ($40,000) and a high one-time interest charge ($34,800), effectively increasing the cost of capital.
- The conversion price is set at 75% of the lowest closing bid price over the 10 trading days preceding conversion, which is highly dilutive to existing shareholders.
- The company is subject to strict covenants and potential liquidated damages for non-compliance, including registration statement failures.
Risks
- Significant dilution risk to existing shareholders due to the variable conversion price mechanism.
- Potential for high default interest (22%) if the company fails to meet payment obligations.
- The company must obtain shareholder approval for the issuance of shares exceeding the exchange cap, creating a regulatory and operational hurdle.
- The note contains numerous events of default, including failure to maintain listing or timely file SEC reports, which could trigger immediate repayment of 150% of the outstanding balance.
Future Outlook
The company intends to use the proceeds for business development and general working capital. It is obligated to file a registration statement for the resale of conversion and warrant shares within 60 days of the issue date.
Management Comments
- Management has authorized the issuance of the securities and confirmed that no further shareholder approval is required for the initial issuance, though future conversion may require it.
Industry Context
StockSavvy.ai notes that this type of financing, often referred to as 'toxic' or 'death spiral' financing, is common among micro-cap companies facing liquidity constraints. The reliance on variable-price convertible notes often signals difficulty in accessing traditional bank debt or equity markets.
Comparison to Industry Standards
- The use of a 25% discount to market price for conversion is aggressive compared to standard convertible debt instruments.
- The 150% default penalty is a punitive measure common in high-risk private placements but significantly higher than standard commercial loan default terms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Restrictive Covenants | Company restricted from changing business nature or selling material assets without holder consent. | 2026-05-12 | Limits management's strategic flexibility. |
Legal Proceedings
- None disclosed, but the agreement mandates binding arbitration in Massachusetts for all disputes.
Related Party Transactions
- None disclosed beyond the standard placement agent fees.
Stakeholder Impact
- Shareholders face potential dilution from the conversion of the note and exercise of warrants.
- Creditors may be impacted by the priority of this debt and the restrictive covenants placed on the company's assets.
Next Steps
- File a registration statement for the resale of conversion and warrant shares within 60 days.
- Purchase directors and officers insurance within 60 days.
- Begin amortization payments on November 12, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-05-12 | Issue date of the promissory note and warrants. |
| 2026-11-12 | Initial exercise date for warrants and start of amortization payments. |
| 2027-05-12 | Maturity date of the promissory note. |
| 2029-05-12 | Termination date for the common stock purchase warrants. |
Recommendation
sellThe issuance of high-cost, dilutive convertible debt is typically a sign of financial distress. Investors should be wary of the potential for significant equity dilution and the restrictive nature of the financing terms.
Keywords
Netcapital, Convertible Note, Securities Purchase Agreement, Dilution, Working Capital, Labrys Fund, NCPL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.